» Articles » PMID: 24391298

Health System Strengthening and Hypertension Awareness, Treatment and Control: Data from the China Health and Retirement Longitudinal Study

Overview
Specialty Public Health
Date 2014 Jan 7
PMID 24391298
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To monitor hypertension prevalence, awareness, treatment and control in China two to three years after major reform of the health system.

Methods: Data from a national survey conducted in 2011-2012 among Chinese people aged 45 years or older - which included detailed anthropometric measurements - were used to estimate the prevalence of hypertension and the percentages of hypertensive individuals who were unaware of, receiving no treatment for, and/or not controlling their hypertension well. Modified Poisson regressions were used to estimate relative risks (RRs).

Findings: At the time of the survey, nearly 40% of Chinese people aged 45 years or older had a hypertensive disorder. Of the individuals with hypertension, more than 40% were unaware of their condition, about 50% were receiving no medication for it and about 80% were not controlling it well. Compared with the other hypertensive individuals, those who were members of insurance schemes that covered the costs of outpatient care were more likely to be aware of their hypertension (adjusted RR, aRR: 0.737; 95% confidence interval, CI: 0.619-0.878) to be receiving treatment for it (aRR: 0.795; 95% CI: 0.680-0.929) and to be controlling it effectively (aRR: 0.903; 95% CI: 0.817-0.996).

Conclusion: In China many cases of hypertension are going undetected and untreated, even though the health system appears to deliver effective care to individuals who are aware of their hypertension. A reduction in the costs of outpatient care to patients would probably improve the management of hypertension in China.

Citing Articles

Health Equity of Hypertension Management Between Local Residents and Internal Migrants in Shenzhen, China: Cross-Sectional Study.

He J, Li Y, Zeng H, Sun H, Wu L, Zhu Z JMIR Public Health Surveill. 2025; 11:e65548.

PMID: 39930994 PMC: 11833189. DOI: 10.2196/65548.


Impact of the National Essential Public Health Service Package on Blood Pressure Control in Chinese People With Hypertension: Retrospective Population-Based Longitudinal Study.

Wei F, Ge Y, Li H, Liu Y JMIR Public Health Surveill. 2025; 11:e65783.

PMID: 39916359 PMC: 11825899. DOI: 10.2196/65783.


Agreement between self-reported and objectively measured hypertension diagnosis and control: evidence from a nationally representative sample of community-dwelling middle-aged and older adults in China.

Wu J, Chen D, Li C, Wang Y Arch Public Health. 2024; 82(1):245.

PMID: 39722079 PMC: 11670411. DOI: 10.1186/s13690-024-01456-5.


Analysis on equity of health service utilization and influencing factors in patients with hypertension in China: a longitudinal study.

Yang X, Lin C, Qin J, Zhang Y, Zhang L BMC Health Serv Res. 2024; 24(1):1644.

PMID: 39716138 PMC: 11667915. DOI: 10.1186/s12913-024-11839-7.


A Systematic Literature Review and Network Meta-analysis of Azilsartan Medoxomil Compared to Other Anti-hypertensives Efficacy in Lowering Blood Pressure Amongst Mild to Moderate Hypertensive Patients.

Qian J, Zhang M, Chen Z Adv Ther. 2024; 41(12):4498-4517.

PMID: 39412629 PMC: 11550241. DOI: 10.1007/s12325-024-02997-5.


References
1.
Tian S, Dong G, Wang D, Liu M, Lin Q, Meng X . Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertens Res. 2011; 34(10):1087-92. DOI: 10.1038/hr.2011.99. View

2.
He J, Gu D, Chen J, Wu X, Kelly T, Huang J . Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009; 374(9703):1765-72. DOI: 10.1016/S0140-6736(09)61199-5. View

3.
Tang C, Luo Z, Fang P, Zhang F . Do patients choose community health services (CHS) for first treatment in China? Results from a community health survey in urban areas. J Community Health. 2013; 38(5):864-72. DOI: 10.1007/s10900-013-9691-z. View

4.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

5.
Chen Z . Launch of the health-care reform plan in China. Lancet. 2009; 373(9672):1322-4. DOI: 10.1016/S0140-6736(09)60753-4. View